3/23/2023 0 Comments Ivermectin covid studiesThe treatment group had 59% lower mortality than the placebo or standard therapy control group (examined in 34 studies involving 44,061 patients), 48% lower use of mechanical ventilation (12 studies 2,316 patients), 57% fewer intensive‐care‐unit admissions (seven studies 21,857 patients), 45% fewer hospitalizations (19 studies 11,190 patients), 71% fewer cases (13 studies 11,523 subjects), 52% faster recovery (23 studies 3,664 patients), and 57% improved viral clearance (22 studies 2,614 patients). Still, the aggregate results are noteworthy. Fifty‐two were peer‐reviewed (18,768 patients).Ī few of the studies have been challenged and even retracted for shoddy work (perhaps putting it kindly), but most have not we will look more carefully at these studies below. Thirty‐one of the studies (6,828 patients) were randomized, controlled trials. We suggest the use of low dose anticoagulants rather than higher doses, unless otherwise indicated.At the time this article was written, the website c19ivermectin.com listed 73 clinical trials of ivermectin and COVID-19, involving 56,774 patients, as having been conducted. Conditional recommendation for the use of low dose anticoagulants in hospitalized patients (this recommendation is part of the clinical management guidelines).Strong recommendation against administering lopinavir/ritonavir for treatment of COVID-19 of any severity.Strong recommendation against the use of hydroxychloroquine or chloroquine for treatment of COVID-19 of any severity.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |